Related references
Note: Only part of the references are listed.Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
Antonio Cervera et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Daniel J. Drucker et al.
LANCET (2008)
Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes
Dennis Kim et al.
DIABETES CARE (2007)
The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes - A randomized trial
Bernard Zinman et al.
ANNALS OF INTERNAL MEDICINE (2007)
Clinical observations of exenatide treatment
Allen B. King et al.
DIABETES CARE (2006)
Exenatide (Exendin-4)-induced pancreatitis - A case report
PS Denker et al.
DIABETES CARE (2006)
Characteristics of autoimmunity in type 1 diabetes and type 1.5 overlap with type 2 diabetes
HO McDevitt
DIABETES (2005)
Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes - A randomized trial
RJ Heine et al.
ANNALS OF INTERNAL MEDICINE (2005)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
DM Kendall et al.
DIABETES CARE (2005)
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
RA DeFronzo et al.
DIABETES CARE (2005)
A randomized, open-label, crossover study examining the effect of injection site on bioavallability of exenatide (synthetic exendin-4)
F Calara et al.
CLINICAL THERAPEUTICS (2005)
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes
LL Nielsen et al.
REGULATORY PEPTIDES (2004)
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia
KB Degn et al.
DIABETES (2004)
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
JJ Holst et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse et al.
DIABETES CARE (2004)
Glycemic control from 1988 to 2000 among U.S adults diagnosed with type 2 diabetes - A preliminary report
CE Koro et al.
DIABETES CARE (2004)
Exendin-4 pharmacodynamics: Insights from the hyperglycemic clamp technique
DE Mager et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes
MS Fineman et al.
DIABETES CARE (2003)
Synthetic exendin-4 (Exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes
OG Kolterman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
JD McGarry
DIABETES (2002)
Pharmacologic therapy for type 2 diabetes mellitus
RA DeFronzo
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
